Post-Surgical Pain Management in Dogs: Multimodal Protocol
TL;DR
- Post-surgical pain management in dogs relies on multimodal analgesia — combining drug classes (NSAID + opioid ± gabapentin ± local block) to target multiple pain pathways simultaneously.
- Pre-emptive analgesia (started before the surgical incision) produces better outcomes than reactive dosing.
- NSAIDs remain the cornerstone for home-going analgesia; opioids cover the acute in-hospital window; gabapentin and local anaesthetics extend comfort and reduce opioid requirements.
- No single drug adequately controls moderate-to-severe surgical pain on its own.
- Owner monitoring for breakthrough pain — using validated scales — is essential for the first 72 hours after discharge.
Why Multimodal Analgesia Matters in Canine Surgery
Post surgical pain management in dogs has shifted dramatically over the past two decades. Where once a single injection of an opioid was considered adequate, the current standard of care — endorsed by the WSAVA Global Pain Council and the AAHA/AAFP Pain Management Guidelines — demands a multimodal approach that combines agents acting on different points of the nociceptive pathway.
The rationale is straightforward: surgical trauma activates peripheral nociceptors (inflammatory pain), sensitizes dorsal horn neurons (central sensitization), and can trigger maladaptive neuroplastic changes that perpetuate pain well beyond tissue healing. No single analgesic class addresses all three mechanisms. By layering an NSAID (peripheral inflammation), an opioid (central modulation), a gabapentinoid (central sensitization), and a local anaesthetic block (afferent nerve conduction), clinicians achieve synergistic pain relief at lower individual doses — reducing the incidence of side effects from any one agent.
Common canine surgeries — tibial plateau levelling osteotomy (TPLO), ovariohysterectomy (spay), castration, mass removal, cruciate repair, and fracture stabilisation — each carry predictable tissue-injury profiles. Matching the analgesic protocol to the expected pain severity is the foundation of responsible perioperative care.
Assessing Pain: Validated Scoring Tools
Effective treatment begins with accurate measurement. Subjective "the dog looks comfortable" appraisals miss up to 50 % of pain events. The WSAVA recommends validated, composite pain scales:
| Scale | Developer | Species | Setting | Key features |
|---|---|---|---|---|
| Glasgow Composite Pain Scale — Short Form (GCPS-SF) | University of Glasgow | Dog | In-hospital | 6 behavioural categories, intervention threshold ≥ 6/24 |
| Colorado State University Acute Pain Scale | CSU | Dog, Cat | In-hospital | Visual/palpation cues, 0–4 scale |
| Helsinki Chronic Pain Index (HCPI) | University of Helsinki | Dog | Owner-assessed | 11-question survey; validated for orthopaedic pain |
| CBPI (Canine Brief Pain Inventory) | UPenn | Dog | Owner-assessed | Pain severity + pain interference scores |
Key clinical takeaway: Assign a pain score before premedication, at extubation, every 1–2 hours for the first 6 hours post-surgery, then every 4–6 hours until discharge. Re-assess whenever the score approaches the intervention threshold and administer rescue analgesia promptly.
Evidence-Based Analgesic Options: Drug Class Comparison
The table below summarises the four pillars of canine postoperative analgesia, their primary mechanism, and where they fit in a multimodal protocol.
| Drug class | Representative agents (INN) | Primary mechanism | Typical role in protocol | Duration of postoperative use |
|---|---|---|---|---|
| NSAIDs | carprofen, meloxicam, robenacoxib, grapiprant | COX-1/COX-2 inhibition (grapiprant: EP4 receptor antagonist) | Cornerstone anti-inflammatory; used peri- and postoperatively | 3–14 days depending on procedure |
| Opioids | methadone, hydromorphone, buprenorphine, fentanyl | μ-opioid receptor agonism (full or partial) | Acute severe pain; premedication and immediate postop period | 12–72 hours (in-hospital) |
| Gabapentinoids | gabapentin, pregabalin | α2δ calcium channel subunit binding; reduces central sensitization | Adjunct for orthopaedic/neuropathic pain | 5–14 days; taper before discontinuation |
| Local anaesthetics | bupivacaine, lidocaine, bupivacaine liposome injectable suspension | Sodium channel blockade | Intraoperative/immediate postop nerve or wound block | Single application; liposomal form lasts up to 72 h |
Head-to-head: When to choose which NSAID
- Carprofen (Rimadyl): Most extensively studied in dogs; licensed for perioperative use in many jurisdictions. Preferential COX-2 selectivity. Available injectable and oral formulations.
- Meloxicam (Metacam): Once-daily oral dosing; widely used globally. Higher COX-2 selectivity than carprofen. Loading dose on day one, then maintenance.
- Robenacoxib (Onsior): Highly COX-2 selective with short plasma half-life but prolonged tissue concentrations at inflamed sites. Licensed for up to 3 days perioperatively in some markets.
- Grapiprant (Galliprant): Piprant class — blocks the EP4 prostaglandin receptor downstream of COX enzymes. Spares COX-1 gastroprotective effects. Particularly useful in dogs with pre-existing renal concerns or GI sensitivity, though clinical data in the immediate perioperative setting are still accumulating.
Dosing Protocols by Procedure Severity
Mild pain (castration, small skin mass removal)
| Agent | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| carprofen | 4.4 mg/kg (or 2.2 mg/kg q12h) | PO | q24h | 3–5 days |
| buprenorphine | 0.01–0.02 mg/kg | IV or IM | q6–8h | In-hospital only (day of surgery) |
| bupivacaine (0.5 %) | 1–2 mg/kg (diluted) | Local infiltration | Once | Intraoperative |
Moderate pain (ovariohysterectomy, large mass removal, dental extractions)
| Agent | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| meloxicam | 0.2 mg/kg day 1, then 0.1 mg/kg | PO or SC (day 1) | q24h | 5–7 days |
| methadone | 0.2–0.3 mg/kg | IV or IM | q4–6h | 12–24 hours postop |
| gabapentin | 5–10 mg/kg | PO | q8–12h | 5–7 days; taper over 2–3 days |
| bupivacaine (0.5 %) | 1–2 mg/kg | Splash block / line block | Once | Intraoperative |
Severe pain (TPLO, fracture repair, thoracotomy, limb amputation)
| Agent | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| carprofen or meloxicam | As above | PO (or IV/SC day 1) | q24h | 10–14 days |
| hydromorphone | 0.05–0.2 mg/kg | IV or IM | q4–6h | 24–48 hours in-hospital |
| fentanyl CRI | 2–5 µg/kg/h | IV | Continuous | Duration of hospitalisation; wean gradually |
| gabapentin | 5–10 mg/kg | PO | q8h | 10–14 days; taper |
| bupivacaine liposome injectable (Nocita) | 5.3 mg/kg | Local infiltration at surgical site | Once | Up to 72 hours of local analgesia |
| amantadine (if central sensitization suspected) | 3–5 mg/kg | PO | q24h | 14–21 days |
Pre-emptive dosing: Administer the NSAID and first opioid dose as part of the premedication — before the surgical incision — whenever haemodynamic status and renal perfusion allow. Pre-emptive analgesia blunts central sensitization more effectively than equivalent doses given after tissue injury has occurred.
Local and Regional Anaesthetic Techniques
Local anaesthetic blocks deserve special emphasis because they provide the most complete afferent blockade achievable — effectively silencing nociceptive input at the source.
Commonly used techniques in dogs:
- Incisional line block / splash block: Bupivacaine 0.5 % (1–2 mg/kg) infiltrated along the incision edges before closure. Simple, requires no specialised equipment. Duration approximately 4–6 hours.
- Liposomal bupivacaine (Nocita): FDA-approved for dogs (and cats for onychectomy). Infiltrated into the tissue at the surgical site; provides local analgesia for up to 72 hours, significantly reducing the need for systemic opioids during the critical first three postoperative days.
- Epidural analgesia: Morphine (0.1 mg/kg) ± bupivacaine (1 mg/kg) injected into the lumbosacral epidural space. Excellent for hindlimb and pelvic procedures (TPLO, femoral fracture, hip surgery). Duration 12–24 hours for morphine component.
- Peripheral nerve blocks: Femoral and sciatic nerve blocks for hindlimb surgery; brachial plexus block for forelimb procedures. Ultrasound guidance improves success rates and reduces complications.
- Intra-articular injection: Bupivacaine (1–1.5 mg/kg, diluted) instilled into the joint after arthrotomy or arthroscopy. Some concern exists regarding chondrotoxicity with repeated or high-concentration exposure; single perioperative use appears safe.
Do not combine liposomal bupivacaine (Nocita) with plain bupivacaine, lidocaine, or other local anaesthetics at the same site — co-administration disrupts the liposomal matrix and accelerates drug release, negating the extended-duration benefit.
Side Effects and Monitoring
NSAID-related concerns
- Gastrointestinal: Vomiting, diarrhoea, melaena, gastric ulceration. Risk increases with concurrent corticosteroids (this combination is contraindicated).
- Renal: Reduced renal blood flow; use with caution in hypovolaemic, hypotensive, or dehydrated patients. Ensure adequate fluid resuscitation before administering perioperative NSAIDs.
- Hepatic: Idiosyncratic hepatotoxicity reported with carprofen (rare; Labrador Retrievers may be overrepresented). Monitor if treatment exceeds 7 days.
- Coagulation: COX-1 inhibition impairs platelet aggregation; generally not clinically significant at recommended NSAID doses but relevant in patients with pre-existing coagulopathies.
Opioid-related concerns
- Respiratory depression (dose-dependent; most relevant with fentanyl CRI — monitor SpO₂).
- Bradycardia (especially methadone, hydromorphone — anticholinergic pretreatment rarely necessary in healthy dogs but monitor HR).
- Dysphoria / sedation: more common with higher doses or in certain breeds.
- GI stasis, inappetence, nausea.
- Panting — often mistaken for pain; distinguish using a validated pain scale before administering rescue analgesia.
- Urinary retention (uncommon; more relevant with epidural morphine).
Gabapentin-related concerns
- Sedation (primary dose-limiting effect; often therapeutic in the anxious postoperative patient).
- Ataxia at higher doses.
- Do not discontinue abruptly after more than 5–7 days of use — taper over 2–3 days to avoid rebound hyperalgesia.
- Formulations containing xylitol (a sweetener toxic to dogs) exist in human liquid gabapentin preparations — verify the formulation before dispensing.
Contraindications and Drug Interactions
| Combination or condition | Risk | Recommendation |
|---|---|---|
| NSAID + corticosteroid | Severe GI ulceration and perforation | Absolutely contraindicated — allow a 5–7 day washout between agents |
| Two NSAIDs concurrently | Additive GI and renal toxicity | Contraindicated — never combine; washout 24–72 h when switching |
| NSAID in hypovolaemic / hypotensive patient | Acute kidney injury | Delay NSAID until normovolaemia and stable blood pressure achieved |
| NSAID in patients on ACE inhibitors or diuretics | Reduced renal perfusion | Use with caution; monitor creatinine and urine output |
| Gabapentin liquid (human formulation) + dog | Xylitol toxicity (hypoglycaemia, hepatic necrosis) | Use capsules, tablets, or veterinary compounded liquid only |
| Tramadol as sole postoperative analgesic | Inadequate analgesia — dogs are poor CYP2D6 metabolisers and produce minimal active M1 metabolite | Not recommended as sole agent; if used, combine with NSAID ± gabapentin |
| Opioid + serotonergic drugs (e.g., trazodone at high doses) | Serotonin syndrome (rare in dogs but reported) | Monitor for agitation, tremors, hyperthermia |
| Liposomal bupivacaine + plain local anaesthetic at same site | Premature liposome disruption; loss of extended release | Do not co-administer locally |
Special Populations
Paediatric patients (< 12 weeks)
Neonatal and juvenile dogs have immature hepatic enzyme systems. Opioid metabolism is slower — reduce opioid doses by 25–50 % and extend dosing intervals. Most NSAIDs lack safety data in puppies under 6 weeks; carprofen and meloxicam are generally considered acceptable from 6–8 weeks of age onward for short courses. Gabapentin clearance is also reduced; start at the low end of the dose range.
Geriatric and renally compromised patients
Age-related decline in GFR warrants baseline renal values (creatinine, SDMA, urinalysis) before any NSAID course exceeding 3 days. Grapiprant, with its COX-sparing mechanism, may offer a favourable safety profile in these patients, although prospective perioperative data in dogs with chronic kidney disease remain limited. Reduce opioid doses as hepatic clearance may be diminished.
Brachycephalic breeds
Brachycephalic dogs (Bulldogs, Pugs, French Bulldogs) have heightened sensitivity to opioid-induced respiratory depression. Use short-acting opioids, monitor closely, and ensure a secure airway during recovery. Sedation from gabapentin, while usually mild, warrants additional vigilance in these breeds.
Sight hounds (Greyhounds, Whippets)
Greyhounds exhibit prolonged recovery from certain injectable agents and have altered NSAID pharmacokinetics due to lower body fat and unique CYP enzyme activity. Standard NSAID doses are generally tolerated, but monitor more frequently.
Cats — critical safety note
Although this article focuses on dogs, multimodal protocols are equally important in cats. However, cats are exceptionally sensitive to NSAID toxicity — their deficient glucuronidation pathways dramatically prolong NSAID half-lives. Meloxicam is used at much lower doses (0.05 mg/kg PO q24h after a 0.1–0.2 mg/kg loading dose), and long-term daily NSAID use in cats requires careful renal monitoring. Paracetamol (acetaminophen) is absolutely contraindicated in cats — even a single dose can cause fatal methaemoglobinaemia and hepatic necrosis.
Red Flags: When to Seek Veterinary Care Immediately
Owners should be clearly instructed — verbally and in writing — to contact their veterinarian or an emergency clinic if any of the following occur after surgery:
- Vomiting blood or producing black/tarry stools (GI haemorrhage — possible NSAID complication)
- Acute abdominal distension with non-productive retching (gastric dilatation-volvulus — surgical emergency)
- Pale or white gums, collapse, or extreme lethargy (internal haemorrhage, shock)
- Swelling, discharge, or dehiscence at the surgical site (wound complication or infection)
- Inability to urinate for more than 12–18 hours (possible urinary retention from opioids or epidural)
- Seizure activity (rare — reported with accidental overdose of local anaesthetics or tramadol)
- Pain that worsens despite medication or dog becomes progressively more withdrawn, reluctant to move, or aggressive when touched near the surgical site
- Excessive sedation, inability to rouse, or very slow breathing (opioid or gabapentin overdose)
Provide owners with a written pain-monitoring checklist and contact numbers before discharge.
Owner Guidance: Managing Pain at Home
- Administer all prescribed medications on schedule — do not skip doses because "the dog seems fine." Subclinical pain is common and worsens outcomes.
- Give NSAIDs with food to reduce GI irritation.
- Restrict activity as directed (lead walks only, no jumping, no stairs if orthopaedic surgery).
- Use a validated owner-assessment tool (CBPI or the clinic's discharge pain checklist) to score pain at least twice daily for the first 3–5 days.
- Do not administer human medications (ibuprofen, naproxen, paracetamol) — all carry serious toxicity risks in dogs.
- Gabapentin may cause noticeable drowsiness for the first 24–48 hours; this typically resolves. Report persistent profound sedation.
- Keep the cone / e-collar on to prevent incision licking, which exacerbates inflammation and pain.
- If prescribed a fentanyl patch, ensure the dog cannot chew or remove it. Accidental ingestion of a fentanyl patch is a life-threatening emergency — contact a veterinarian and poison control immediately.
Frequently Asked Questions
Q: How long will my dog need pain medication after surgery? A: It depends on the procedure. Minor surgeries (castration, small lump removal) typically require 3–5 days of an NSAID alone. Orthopaedic procedures (TPLO, fracture repair) often need 10–14 days of an NSAID plus gabapentin, with opioids limited to the first 24–48 hours in hospital. Your veterinarian will tailor the duration to your dog's pain scores.
Q: Is tramadol effective for dogs? A: Tramadol has limited efficacy as a sole analgesic in dogs because canine liver enzymes produce very little of the active metabolite (O-desmethyltramadol) responsible for opioid-like pain relief. Current WSAVA and AAHA guidelines do not recommend tramadol as a primary postoperative analgesic for dogs. If used at all, it should be part of a multimodal protocol — never the only pain medication.
Q: Can I give my dog ibuprofen or aspirin from my medicine cabinet? A: No. Human NSAIDs such as ibuprofen and naproxen have a very narrow safety margin in dogs and frequently cause gastric ulceration, renal failure, and even death. Aspirin irreversibly inhibits platelet function and should not be combined with veterinary NSAIDs. Always use veterinary-prescribed pain medications.
Q: What is Nocita, and why is it expensive? A: Nocita is a liposomal formulation of bupivacaine (bupivacaine liposome injectable suspension) approved by the FDA for use in dogs and cats. The liposomal encapsulation allows gradual drug release over approximately 72 hours, providing extended local analgesia from a single infiltration at the surgical site. The cost reflects the proprietary technology and the significant reduction in postoperative opioid requirements it provides.
Q: My dog is panting heavily after surgery — is that pain? A: Panting can indicate pain, but it is also a common side effect of opioids, anxiety, nausea, or mild hyperthermia. The most reliable approach is to use a validated pain scale (such as the Glasgow CMPS-SF) to differentiate. If the pain score is below the intervention threshold and the dog is otherwise comfortable, panting alone may not warrant additional analgesia. Consult your veterinary team.
Q: Is gabapentin safe long-term for my dog? A: Gabapentin is generally well tolerated in dogs with sedation as the most common adverse effect. For postoperative use, courses of 7–14 days are typical. Longer-term use (weeks to months) is common for chronic pain conditions such as osteoarthritis or neuropathic pain and is considered safe, though periodic reassessment is advisable. Always taper rather than stop abruptly.
Q: Should pain medication be given before surgery or only after? A: Before. Pre-emptive analgesia — administering analgesics before the surgical stimulus — is a core principle of modern veterinary pain management. It reduces central sensitization, lowers total postoperative analgesic requirements, and improves recovery quality. Your veterinarian will typically include an opioid and often an NSAID in the premedication.
Q: How do I know if the pain protocol is working? A: A successful protocol results in a dog that rests comfortably, responds normally to gentle interaction, eats within 12–24 hours of surgery, and has pain scores consistently below the intervention threshold on validated scales. If your dog remains restless, vocalises, guards the surgical site, refuses food beyond 24 hours, or becomes withdrawn, report these signs — the protocol may need adjustment.
References
-
Mathews K, Kronen PW, Lascelles D, et al. Guidelines for Recognition, Assessment and Treatment of Pain. J Small Anim Pract. 2014;55(6):E10–E68. PMID: 24841489
-
Epstein ME, Rodan I, Griffenhagen G, et al. 2015 AAHA/AAFP Pain Management Guidelines for Dogs and Cats. J Am Anim Hosp Assoc. 2015;51(2):67–84. PMID: 25764070
-
Lascelles BDX, McFarland JM, Swann H. Guidelines for Safe and Effective Use of NSAIDs in Dogs. Vet Ther. 2005;6(3):237–251. PMID: 16299670
-
KuKanich B. Outpatient Oral Analgesics in Dogs and Cats Beyond Nonsteroidal Antiinflammatory Drugs: An Evidence-Based Approach. Vet Clin North Am Small Anim Pract. 2013;43(5):1109–1125. PMID: 23890241
-
Rialland P, Authier S, Bhatt M, et al. Review of Analgesic Pathophysiology and Multimodal Drug Approaches in Canine Acute Pain. Can Vet J. 2022;63(2):157–168. PMID: 35110808
-
FDA. NADA 141-450: NOCITA (bupivacaine liposome injectable suspension) for Dogs and Cats. 2016, updated 2018. FDA Animal Drug Approvals
-
Gruen ME, Lascelles BDX, Essner A, et al. Canine Brief Pain Inventory — Reliability and Discriminatory Ability for Rating Pain in Dogs. J Vet Intern Med. 2015;29(1):341. Canine BPI Validation
-
WSAVA Global Pain Council. WSAVA Pain Management Guidelines — Toolkit and Resources. wsava.org/guidelines/global-pain-council-guidelines
-
Reid J, Nolan AM, Hughes JML, et al. Development of the Short-Form Glasgow Composite Measure Pain Scale (CMPS-SF) and Derivation of an Analgesic Intervention Score. Anim Welf. 2007;16(S):97–104. Glasgow Pain Scale — NewMetrica
-
Monteiro BP, Steagall PV. Antiinflammatory Drugs. Vet Clin North Am Small Anim Pract. 2019;49(6):993–1011. PMID: 31375256
About the Author
Dr. Stanislav Ozarchuk, PharmD, is a clinical pharmacist with 15 years of experience spanning hospital, community, and consultative practice. He writes for PillsCard.com, translating complex pharmacological evidence into practical guidance for patients, caregivers, and healthcare professionals worldwide. His work emphasises evidence-based medicine, guideline adherence, and clear communication of drug safety principles across both human and veterinary pharmacotherapy.
Medical Disclaimer
This article is provided for educational and informational purposes only and does not constitute veterinary medical advice, diagnosis, or treatment. Drug doses, protocols, and recommendations described herein are based on published guidelines and peer-reviewed literature available at the time of writing, but individual patient needs may vary. Always consult a licensed veterinarian before starting, changing, or discontinuing any medication for your animal. Do not administer human medications to animals without veterinary direction. PillsCard.com and the author assume no liability for actions taken based on the information presented in this article.